Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel with Platinum in 1st Line Ovarian Cancer
NCT00539669Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in epithelial ovarian carcinoma (EOC), sponsored by Sanofi. Started Mar 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
epithelial ovarian carcinoma (EOC)
Beyond the preview
Go deeper on NCT00539669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539669.